About us

Apercure Surgical was founded by a surgeon and a scientist with over 50 years of combined experience, bringing firsthand clinical insights into solving everyday challenges in healthcare. Emerging from a pioneering medical device design studio at the University of Auckland, New Zealand, our mission is to create practical, impactful solutions that improve patient outcomes while delivering economic value to healthcare providers. By leveraging rapid design, prototyping, and testing, we specialise in developing innovative medical device solutions. 


Our current focus is on enhancing the security and comfort of drain retention devices for medical and radiological interventions. These advancements aim to transform the experiences of both patients and clinicians, ensuring better outcomes and streamlined procedures.


Our team of clinical, scientific, and engineering experts share a commitment to advancing healthcare, guided by flexibility and a readiness to adapt to evolving market needs and technological developments.

News

LIMPIT In-Hospital Clinical Trial Complete 


12 March 2026

Apercure Surgical is pleased to announce the successful completion of its first in-hospital clinical trial evaluating the LIMPIT® securement and wound management device for percutaneous drainage catheters and surgical drains.


Conducted at a leading New Zealand public hospital, the study assessed the safety, usability, and clinical performance of LIMPIT® across a broad range of surgical and interventional procedures. The trial marks a significant milestone in the commercial and regulatory advancement of the device and represents a major step toward international market entry.


LIMPIT In-Hospital Clinical Trial Underway 


20 October 2025

Apercure Initiates In-Hospital Clinical Trial of the LIMPIT®.


Apercure Surgical Limited is pleased to announce the commencement of its first in-hospital clinical trial for the LIMPIT® device — a next-generation securement solution for percutaneous drainage catheters and surgical drains.


The study, conducted at a leading New Zealand public hospital, marks a major step forward in validating LIMPIT’s performance in a real-world clinical setting. The trial is designed to evaluate the device’s safety, usability, and clinical efficacy across a representative cohort of surgical patients and procedures.


LIMPIT First human Cinical Trial Completed


15 February 2025


Apercure achieves major milestone with successful completion of first human clinical trial for LIMPIT® surgical device


Apercure Surgical Limited is pleased to announce the successful completion of its first clinical trial for the LIMPIT® device , a next-generation solution for securement of surgical drains. The trial evaluated the device's safety, usability, and effectiveness in a real-world clinical setting. Results confirmed that LIMPIT delivers measurable improvements in surgical precision, reduces drain-related complications, and enhances post-operative recovery when compared to traditional methods. 


More News 

Get in Touch

We’re here to help! Whether you have questions about our products, services, or clinical trials, or you’re looking to collaborate on an innovative idea, we’d love to hear from you.

Monday

9:00 am - 6:30 pm

Tuesday

9:00 am - 6:30 pm

Wednesday

9:00 am - 6:30 pm

Thursday

9:00 am - 6:30 pm

Friday

9:00 am - 6:30 pm